Stay updated with breaking news from Neuronetics Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BLB&B Advisors LLC bought a new position in Neuronetics, Inc. (NASDAQ:STIM – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 29,937 shares of the company’s stock, valued at approximately $64,000. BLB&B Advisors LLC owned approximately 0.11% of Neuronetics […]
Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) CEO Keith J. Sullivan sold 6,551 shares of the firm’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $2.04, for a total transaction of $13,364.04. Following the completion of the transaction, the chief executive officer now directly owns 1,177,658 […]
Cannell Capital LLC lessened its holdings in shares of Neuronetics, Inc. (NASDAQ:STIM – Get Rating) by 6.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,246,131 shares of the company’s stock after selling 217,715 shares during the period. Neuronetics accounts […]
Neuronetics (NASDAQ:STIM – Get Rating) and Rosecliff Acquisition Corp I (NASDAQ:RCLF – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership. Earnings and Valuation This table compares Neuronetics and […]
First Eagle Investment Management LLC grew its holdings in Neuronetics, Inc. (NASDAQ:STIM – Get Rating) by 6.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 367,893 shares of the company’s stock after acquiring an additional 21,101 shares during the period. First […]